Table 4.
Measure | Baseline | 12 Weeks | Effect Size |
Structural volume (cm3) | |||
Total grey mattera | 633.0±32.7 | 637.6±25.6 | 0.38* |
Hippocampus | 7.74±0.57 | 7.75±0.51 | 0.05 |
CA1 | 2.69±0.27 | 2.69±0.29 | 0.07 |
Dentate gyrus | 1.65±0.14 | 1.63±0.14 | 0.26 |
Entorhinal cortex | 0.92±0.10 | 0.92±0.10 | 0.02 |
Cortical thickness (mm3) | |||
Superior parietal lobulea | 4.57±0.27 | 4.59±0.27 | 0.30* |
Superior frontal gyrus | 5.30±0.23 | 5.32±0.26 | 0.26 |
Middle frontal gyrus | 9.71±0.42 | 9.78±0.46 | 0.56* |
Inferior frontal gyrusa | 15.07±0.89 | 15.17±1.14 | 0.15 |
CB flow - ICA and VAb | |||
Pulsatility index | 1.24±0.41 | 1.11±0.38 | 0.47 |
Resistivity index | 0.67±0.11 | 0.65±0.10 | 0.30 |
CSF flow - Subarachnoid spaceb | |||
Stroke volume (mm3)a | 436.2±177.0 | 527.3±297.3 | 0.28 |
Flush peak (mm3/s) | 1972±572 | 2194±776 | 0.51* |
CSF flow - Aqueductb | |||
Stroke volume (mm3)a | 47.8±48.5 | 57.6±30.5 | 0.19 |
Flush peak (mm3/s) | 209.1±74.7 | 220.8±58.2 | 0.20 |
Cerebral perfusionb,c | 36.6±9.3 | 38.2±7.4 | 0.13 |
Descriptive statistics are reported as mean±SD and effect sizes reported using Cohen’s d unless otherwise specified. aData not normally distributed so statistics reported as median±IQR and effect sizes reported using test statistic from non-parametric Wilcoxon signed rank test. bOne participant was excluded due to wearing a facemask while in MRI scanner. cPCASL sequence not acquired in one participant. *Medium effect sizes associated with pre- to post-intervention changes.